Regeneron Pharmaceuticals Inc (REGN)
701.85
-6.40
(-0.90%)
USD |
NASDAQ |
Dec 20, 16:00
697.88
-3.97
(-0.57%)
After-Hours: 06:21
Regeneron Pharmaceuticals Cash from Investing (Quarterly): -574.40M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Eli Lilly and Co | -4.005B |
| Pfizer Inc | -2.057B |
| Biogen Inc | -1.181B |
| AbbVie Inc | -8.256B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.291B |
| Cash from Financing (Quarterly) | -634.00M |
| Free Cash Flow | 3.319B |
| Free Cash Flow Per Share (Quarterly) | 9.030 |
| Free Cash Flow to Equity (Quarterly) | 1.049B |
| Free Cash Flow to Firm (Quarterly) | 1.049B |
| Free Cash Flow Yield | 4.11% |